rs141368794

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4BS1_SupportingBS2_Supporting

The NM_002547.3(OPHN1):​c.1613A>G​(p.Asp538Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000331 in 1,208,260 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. D538D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.000031 ( 0 hom. 10 hem. )

Consequence

OPHN1
NM_002547.3 missense

Scores

3
5
8

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3O:1

Conservation

PhyloP100: 7.49

Publications

2 publications found
Variant links:
Genes affected
OPHN1 (HGNC:8148): (oligophrenin 1) This gene encodes a Rho-GTPase-activating protein that promotes GTP hydrolysis of Rho subfamily members. Rho proteins are important mediators of intracellular signal transduction, which affects cell migration and cell morphogenesis. Mutations in this gene are responsible for OPHN1-related X-linked cognitive disability with cerebellar hypoplasia and distinctive facial dysmorhphism. [provided by RefSeq, Jul 2008]
OPHN1 Gene-Disease associations (from GenCC):
  • X-linked intellectual disability-cerebellar hypoplasia syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.38885957).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000538 (6/111513) while in subpopulation NFE AF = 0.000113 (6/53070). AF 95% confidence interval is 0.0000485. There are 0 homozygotes in GnomAd4. There are 2 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAd4 at 2 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OPHN1NM_002547.3 linkc.1613A>G p.Asp538Gly missense_variant Exon 19 of 25 ENST00000355520.6 NP_002538.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OPHN1ENST00000355520.6 linkc.1613A>G p.Asp538Gly missense_variant Exon 19 of 25 1 NM_002547.3 ENSP00000347710.5

Frequencies

GnomAD3 genomes
AF:
0.0000538
AC:
6
AN:
111513
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000113
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000328
AC:
6
AN:
183187
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000489
Gnomad OTH exome
AF:
0.000443
GnomAD4 exome
AF:
0.0000310
AC:
34
AN:
1096747
Hom.:
0
Cov.:
30
AF XY:
0.0000276
AC XY:
10
AN XY:
362229
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26360
American (AMR)
AF:
0.00
AC:
0
AN:
35192
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19374
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54091
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40516
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3958
European-Non Finnish (NFE)
AF:
0.0000404
AC:
34
AN:
841022
Other (OTH)
AF:
0.00
AC:
0
AN:
46032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000538
AC:
6
AN:
111513
Hom.:
0
Cov.:
22
AF XY:
0.0000593
AC XY:
2
AN XY:
33719
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30687
American (AMR)
AF:
0.00
AC:
0
AN:
10466
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3527
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2612
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6097
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000113
AC:
6
AN:
53070
Other (OTH)
AF:
0.00
AC:
0
AN:
1484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000174
Hom.:
1
Bravo
AF:
0.0000151
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.0000247
AC:
3
EpiCase
AF:
0.00
EpiControl
AF:
0.0000595

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

X-linked intellectual disability-cerebellar hypoplasia syndrome Uncertain:1Other:1
Aug 18, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant classified as Uncertain significance and reported on 12-15-2018 by Ambry Genetics. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant.

not specified Uncertain:1
Feb 03, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Uncertain:1
Jul 08, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1613A>G (p.D538G) alteration is located in exon 19 (coding exon 18) of the OPHN1 gene. This alteration results from a A to G substitution at nucleotide position 1613, causing the aspartic acid (D) at amino acid position 538 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.47
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.27
T
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.96
D
M_CAP
Benign
0.041
D
MetaRNN
Benign
0.39
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L
PhyloP100
7.5
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-4.3
D
REVEL
Benign
0.26
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0010
D
Vest4
0.43
ClinPred
0.68
D
GERP RS
4.4
Varity_R
0.80
gMVP
0.75
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141368794; hg19: chrX-67316785; COSMIC: COSV62780956; API